Break through innovations saving lives

About
DigiLife

Digilife is a venture capital fund focused on healthcare technology companies. We specialize in investing in, and nurturing, early-stage startup companies that apply new-age technologies to complex problems in healthcare. We invest in entrepreneurs with unique ideas and strong motivations to succeed. We are a team of professionals with diverse backgrounds working together to help build great companies that can make a significant impact for the benefit of patients worldwide.

Vision

Our vision is to invest in early-stage companies to support innovative entrepreneurs building breakout growth companies that improve lives through prediction, prevention, and personalization while building value for our limited and general partners.

Mission

Investing at the convergence of biology & technology to improve the health & well-being of people around the world by solving major healthcare problems of accessibility, affordability and improving quality of healthcare.

Our investments

We believe in nurturing ideas and building companies.

Why we are Different

We invest in early-stage companies that deploy artificial intelligence to predict a diagnosis of health conditions and those that can prevent them from occurring.

We believe in the convergence of biology and technology to activate clinical action that improves patient outcomes.

We make high-impact investments in digital health and health-tech companies with breakthrough teams and technologies.

We have deep relationships with Stanford Biodesign, Duke’s Institute for Health Innovation, Pepperdine University Business School, C-CAMP, and a diverse global and cross-border partnerships that continue to feed us steady deal flow.

Our team members are successful global venture investors and founders, entrepreneurs, and CEOs of private equity and Nasdaq, NYSE and ASE-listed public companies with operating experience across the healthcare and life sciences spectrum.